+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Continuous Renal Replacement Therapy (CRRT) - Global Strategic Business Report

  • PDF Icon

    Report

  • 216 Pages
  • February 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4804629

Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $2.1 Billion by 2030

The global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.3 Billion in the year 2022, is projected to reach a revised size of US$2.1 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2022-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Disposables & Systems segment is estimated at 6.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $351 Million, While China is Forecast to Grow at 8.4% CAGR

The Continuous Renal Replacement Therapy (CRRT) market in the U.S. is estimated at US$351 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$316.6 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 4.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 18 Featured)

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Frequently Asked Questions about the Continuous Renal Replacement Therapy (CRRT) Market

What is the estimated value of the Continuous Renal Replacement Therapy (CRRT) Market?

The Continuous Renal Replacement Therapy (CRRT) Market was estimated to be valued at $1.3 Billion in 2022.

What is the growth rate of the Continuous Renal Replacement Therapy (CRRT) Market?

The growth rate of the Continuous Renal Replacement Therapy (CRRT) Market is 6.2%, with an estimated value of $2.1 Billion by 2030.

What is the forecasted size of the Continuous Renal Replacement Therapy (CRRT) Market?

The Continuous Renal Replacement Therapy (CRRT) Market is estimated to be worth $2.1 Billion by 2030.

Who are the key companies in the Continuous Renal Replacement Therapy (CRRT) Market?

Key companies in the Continuous Renal Replacement Therapy (CRRT) Market include Toray Industries, Inc., B. Braun Melsungen AG, Medtronic PLC, Baxter International, Inc., B. Braun Medical, Inc., Fresenius SE & Co. KGaA, Nikkiso Co., Ltd., Fresenius Medical Care AG & Co. KgaA, Asahi Kasei Medical Co., Ltd. and Medica SpA.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Continuous Renal Replacement Therapy Market Set for a Steady Growth
  • Dialysates & Replacement Fluids Dominate the Market, Disposables to Register the Fastest Growth
  • Continuous Venovenous Hemofiltration (CVVH) Leads the Market, CVVHDF to Exhibit the Fastest Growth
  • Europe and US Hold the Largest Share, China to Witness Fastest Growth
  • Continuous Renal Replacement Therapy (CRRT) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Future Endeavors in CRRT
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increase in Incidence of Acute Kidney Injury to Drive Market Growth
  • Rise in Aging Population, Growing Number of ICU Patients Spurs the Need for CRRT
  • Global Population Statistics for the 60+ Age Group by Region (in Thousands): 2017
  • Rising Incidence of Diabetes: A Key Risk Factor for Acute Kidney Failure
  • TABLE 11: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
  • Increasing Incidence of Cardiovascular Disease Drive Market Growth
  • Prevalence of Heart Failure in Select Countries
  • Advancements in CRRT Machines: Designed for Reliable and Safe Treatment
  • Technological Advancements to Bolster Market Growth
  • Development of CRRT System for Pediatric Patients
  • Miniaturization and Wearable Technology Forays into Acute Renal Replacement Domain
  • Reimbursement Scenario
  • Development of New Hemofilters to Propel Market Expansion
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 3: World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 6: World 16-Year Perspective for Dialysates & Replacement Fluids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 9: World 16-Year Perspective for Disposables & Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 12: World 16-Year Perspective for Continuous Venovenous Hemofiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 15: World 16-Year Perspective for Continuous Venovenous Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 18: World 16-Year Perspective for Continuous Venovenous Hemodiafiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 21: World 16-Year Perspective for Slow Continuous Filtration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 22: World Continuous Renal Replacement Therapy (CRRT) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • JAPAN
  • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • CHINA
  • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 43: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 46: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • EUROPE
  • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • FRANCE
  • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 58: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 61: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • GERMANY
  • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
  • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • REST OF EUROPE
  • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 81: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 82: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 84: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 85: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
  • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 87: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 88: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 90: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 91: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • REST OF WORLD
  • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 93: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 94: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
  • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 96: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 97: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA